Gene · 1457
Papers3,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression. | Hepatol Commun | 2023 | 37347224 | PubTator, text mining | PubMed |
| Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells. | mBio | 2023 | 37341489 | PubTator, text mining | PubMed |
| Analysis of Notch1 signaling in mammalian sperm development. | BMC Res Notes | 2023 | 37337280 | PubTator, text mining | PubMed |
| TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway. | Cell Death Dis | 2023 | 37328464 | PubTator, text mining | PubMed |
| Hybrid-DIA: intelligent data acquisition integrates targeted and discovery proteomics to analyze phospho-signaling in single spheroids. | Nat Commun | 2023 | 37328457 | PubTator, text mining | PubMed |
| The atlastin paralogs: The complexity in the tails. | J Cell Biol | 2023 | 37327452 | PubTator, text mining | PubMed |
| Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy? | Front Mol Neurosci | 2023 | 37305556 | PubTator, text mining | PubMed |
| An in silico approach to identify early damage biomarker candidates in metachromatic leukodystrophy. | Mol Genet Metab Rep | 2023 | 37275681 | PubTator, text mining | PubMed |
| Aspartoacylase suppresses prostate cancer progression by blocking LYN activation. | Mil Med Res | 2023 | 37271807 | PubTator, text mining | PubMed |
| Interactions of Equine Viruses with the Host Kinase Machinery and Implications for One Health and Human Disease. | Viruses | 2023 | 37243249 | PubTator, text mining | PubMed |
| Two novel CSNK2A1 variants associated with mild Okur-Chung neurodevelopmental syndrome phenotype. | Clin Dysmorphol | 2023 | 37195306 | PubTator, text mining | PubMed |
| Regulation of Epithelial Sodium Transport by SARS-CoV-2 Is Closely Related with Fibrinolytic System-Associated Proteins. | Biomolecules | 2023 | 37189326 | PubTator, text mining | PubMed |
| Risk Effects of rs1799945 Polymorphism of the HFE Gene and Intergenic Interactions of GWAS-Significant Loci for Arterial Hypertension in the Caucasian Population of Central Russia. | Int J Mol Sci | 2023 | 37176017 | PubTator, text mining | PubMed |
| Sex-Specific Features of the Correlation between GWAS-Noticeable Polymorphisms and Hypertension in Europeans of Russia. | Int J Mol Sci | 2023 | 37175507 | PubTator, text mining | PubMed |
| Insights from Drosophila on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools. | Front Neurosci | 2023 | 37139514 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Functional Modulation of Transcriptional Coactivator PC4 via Phosphorylation on Its Intrinsically Disordered Region. | ACS Omega | 2023 | 37125110 | PubTator, text mining | PubMed |
| Unraveling the Mechanism of Immunity and Inflammation Related to Molecular Signatures Crosstalk Among Obesity, T2D, and AD: Insights From Bioinformatics Approaches. | Bioinform Biol Insights | 2023 | 37124128 | PubTator, text mining | PubMed |
| Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation. | Front Immunol | 2023 | 37122728 | PubTator, text mining | PubMed |
| Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications. | Life (Basel) | 2023 | 37109432 | PubTator, text mining | PubMed |
| GSK-3β Allosteric Inhibition: A Dead End or a New Pharmacological Frontier? | Int J Mol Sci | 2023 | 37108703 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1457/papers?page=10